Passive laboratory-based surveillance data from the Notifiable Medical Conditions Surveillance System (NMCSSS) was used to describe the epidemiology of HBV surveillance data. All laboratory-confirmed HBV cases notified between January 2020‒September 2022 were included. Province prevalence was calculated using the 2021 mid-year population estimate per 100 000 populations. We summarized the findings using measures of central location (median age with range). Proportions and rates of missing information were calculated and expressed in percentages. 